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Dukarm, Paul D., PhD, May 2006 Clinical Psychology
Detecting Simulated Cognitive Impairment with MMPI-2 Neurocorrection Scales. 
Chairperson: Stuart Hall, PhD.
This study provides the first evidence that special neurocorrection scales of the second 
edition of the Minnesota Multiphasic Personality Inventory (MMPI-2; Butcher, Graham, 
Tellegan, & Kaemmer, 1989) are superior to the Fake Bad Scale (FBS; Lees-Haley, Dunn, 
& English, 1991) at differentiating traumatic brain injury (TBI) simulators compared to 
controls. Two groups of undergraduate psychology students were assigned to either a TBI 
simulator (n = 15) or control group (n = 17). Simulators were instructed to answer the 
MMPI-2 items within the context of simulating late effects of a mild-to-moderate head 
injury while pursuing financial compensation through litigation. A sample of community 
TBI patients (n = 22) was used as a comparison group. Results indicated that the Alfano et 
al. (1993) neurocorrection scale was clinically sensitive to TBI simulation ( d -  3.3), and 
superior to the FBS (d = 1.8) compared to student controls. The Alfano scale achieved a 
sensitivity rate of 86.7% compared to 73.3% for the FBS. Specificity for the Alfano scale 
was 94.1% for an overall hit rate of 90.6%. The FBS achieved a specificity rate of 82.4% 
with a total hit rate of 78.1%. The neurocorrection scales were not effective at 
differentiating TBI simulators from community TBI patients. Limitations include small 
sample size and significant age differences between simulators and community TBI 
patients. The sample was skewed toward females (66%) and Caucasians (95%). Future 
studies should consider applying the neurocorrection scales in known-group studies 
investigating TBI simulation. The validity of MMPI-2 results in neuropsychological 
contexts is discussed.
u
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Detecting Simulated Cognitive Impairment with MMPI-2 Neurocorrection Scales
Introduction
Traumatic brain injury (TBI) is responsible for more deaths and disability than 
any other neurological condition for individuals under age 50 (Center for Disease 
Control, 2004). The United States reports between 1.5 and 3 million new cases of TBI 
annually and up to 75% are classified as "mild" in severity. In spite of this fact, there are 
still 50,000 deaths each year, with 5.3 million Americans estimated to be living with a 
traumatic brain injury. This accounts for an annual figure of approximately 80,000 
Americans experiencing long-term disability related to head trauma.
Clinical neuropsychologists are often called upon to evaluate the degree of 
cognitive impairment secondary to TBI. Many assessment devices, including self-report 
inventories, are often very useful in understanding a variety of psychosocial variables 
associated with cognitive complaints after a head injury. However, these instruments are 
not without certain vulnerabilities. For instance, self-report inventories of personality 
functioning are particularly susceptible to many types of deceptive responding. Attorneys 
have also been known to “coach” clients on how to respond to psychological inventories 
(Youngjohn, 1995).
It has been reported that complaints related to TBI are the most common 
neurological syndrome feigned (Haines & Norris, 1995). Consequently, base rates for 
malingering vary considerably in forensic contexts and have been reported to occur at 
rates up to 40% (Binder & Rohling, 1991; Fox, Lees-Haley, Earnest, & Dolezal-Wood,
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1995; Lees-Haley, Willis, & Brown, 1993; Mittenberg, Patton, Canyock, & Condit,
2002), and 10 times the base rate of bona fide cognitive impairment (Larrabee, 2000). 
These data have prompted clinicians in the field of forensic neuropsychology to 
incorporate measures of effort into their assessments as a standard of practice (Bender & 
Rogers, 2004; Bush et al., 2005; Iverson & Binder, 2000; Slick, Sherman, & Iverson, 
1999).
Nichols and Greene (1997) describe “simulation” as one end of a continuum (i.e. 
ranging from simulation to dissimulation) where simulation refers to masking coping 
resources and simulating a greater degree of impairment than an individual may actually 
be experiencing and dissimulation is where individuals mask impairment in hopes of 
presenting a favorable impression (p. 255). The evaluation of malingering and symptom 
exaggeration poses numerous problems for clinicians. Many have resorted to examining 
constructs that are believed to be directly associated with malingering as well as 
discrepancies in assessment information. One of these constructs is the amount of effort 
one utilizes during the evaluation.
Effort has been defined as the “investment in performing at capacity levels” on a 
given effort based test (Bush, et al., 2005, p. 420). Inferences about performance are 
conceptualized along continuums of effort and honesty in which these two constructs 
may vary given the setting and circumstances of examination. Additional continua 
include intention, or volition, and incentive. The intention continuum ranges from 
conscious, volitional control over the decision to simulate impairment, as in malingering, 
to an unconscious, or unawareness that one is producing the symptoms, such as in
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conversion disorder (Slick, et al., 1999). Regarding incentives or rewards, the range is 
from internal or psychological incentive to an external reward such as financial 
compensation or avoidance of responsibility.
Slick et al. (1999) present criteria for diagnosing the malingering of 
neurocognitive dysfunction based on a variety of pieces of converging evidence. These 
include the presence of a substantial external incentive, negative response bias or failure 
on measures of effort, discrepancies between test data and behavior, inconsistencies 
between test data and reliable collateral reports, and inconsistencies between a person’s 
historical information and test data. Additional considerations for diagnosing malingering 
include differences in cultural background, differential diagnoses, premorbid behavior, 
and the psychometric properties of tests used in the evaluation (Slick, et al., 1999).
Considering recent evidence that suggests that effort accounts for over half of the 
overall variance in neuropsychological test batteries (Green, Rohling, Lees-Haley, & 
Allen, 2001), it is prudent for psychologists to incorporate measures of effort in their 
examinations. The current study focuses on one approach that may improve the ability to 
make accurate judgments about score validity using the second edition of the Minnesota 
Multiphasic Personality Inventory (MMPI-2; Butcher, Dahlstrom, Graham, Tellegan, & 
Kaemmer, 1989).
The MMPI-2 and its predecessor, the MMPI (Hathaway & McKinley, 1943), have 
been the most common personality instruments used by clinical neuropsychologists in the 
United States for a number of years (Camara, Nathan, & Puente, 2000; Lees-Haley, 1992; 
Lubin, Larsen, & Matarazzo, 1984; Rabin, Barr, & Burton, 2005). The MMPI-2 is
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routinely utilized as a measure of psychopathology and personal adjustment in both 
clinical and neuropsychological evaluations and can provide useful information regarding 
the degree of distress and symptoms one is experiencing from a variety of neurological 
conditions (Lezak, Howieson, & Loring, 2004; Reitan & Wolfson, 1993).
The MMPI-2 is also often integrated into forensic and neuropsychological 
evaluations for its well established validity scales that measure exaggeration of 
psychiatric symptoms (Berry, Baer, & Harris, 1991; Graham, Watts, & Timbrook, 1991; 
Rogers, Sewell, & Salekin, 1994). Lees-Haley, English, and Green (1991) developed the 
Fake Bad Scale (FBS) and subsequently validated its use for detecting emotional and 
somatic exaggeration in personal injury evaluations (Larrabee, 1998). Recent research 
also claims that the FBS is a useful measure for detecting exaggeration of cognitive 
complaints associated with head injury (Larrabee, 2003; Martens, Donders, & Millis, 
2001; Ross, Millis, Krukowski, Putnam, & Adams, 2004). This study hypothesizes that 
there may be a superior alternative to the FBS when the primary complaints are related to 
cognitive impairment.
There have been a series of studies that have developed special neurological 
scales from MMPI-2 items that have demonstrated sensitivity to detecting individuals 
with brain injury (Alfano, et al., 1993; Artzy, 1996; Gass, 1991; Gass & Russell, 1991; 
Van Balen, et al., 1997). We propose that these special neurocorrection scales contain 
item content that simulators of traumatic brain injury are more likely to endorse. In 
addition, it is believed that the neurocorrection scales are more sensitive to TBI 
simulation than the Fake Bad Scale.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Neurological Scale Development with the MMPI
The first neurological scale for the MMPI was the Caudality (Ca) scale (Williams, 
1952). The Ca scale contained 37 items and successfully differentiated patients with 
frontal lesions from patients with parietal lesions. Differences in response profiles 
indicated that individuals with frontal lesions were characterized by “inhibition, low 
aspiration, and peculiar thought processes,” where as patients with parietal lesions 
exhibited “introversion, anxiety, and depression” (p. 296).
Creating and applying special neurological scales to identify personality changes 
associated with cognitive impairment became a major focus of research in the years 
following (Meier, 1969). Several researchers developed scales that were designed to 
distinguish between neurological and schizophrenic groups, with follow-up and 
validation studies demonstrating minimal clinical utility (Hovey, 1964; Horton, 1983; 
Horton & Wilson, 1981; Meier & French, 1964; Sand, 1973; Shaw & Mathews, 1973; 
Siskind, 1976; Upper & Seeman, 1968).
Item Bias and Symptom Nonspecificity
In a study which would have substantial impact on how the MMPI was 
interpreted, Ayers, Templar, and Ruff (1975) demonstrated that a scale devised to 
differentiate schizophrenic men from those with brain damage faired no better than scale 
8 -  Schizophrenia in doing so. In a follow-up study, they validated their conclusions by 
reporting that the special neurological scales were related more to indices of 
psychopathology rather than indices of brain damage. In fact, they raised the contention 
that the special scales were biased toward psychopathology in general and schizophrenia
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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specifically (Ruff, Ayers, & Templar, 1977). The study also demonstrated that items 
could be endorsed by diagnostically separate groups, including neurological and 
psychiatric groups with similar symptomatology. When this happens, clinicians 
interpreting the MMPI in the standard fashion can inadvertently equate elevated MMPI 
scales with psychopathology instead of neurological sequelae.
Previous studies have produced equivocal results linking MMPI variables to 
neuropsychological variables (Cripe, 1996). For instance, several studies have indicated 
that the MMPI is insufficient at determining degrees of psychopathology for lateralized 
brain injuries and language disturbances (Dikmen & Reitan, 1974a; Dikmen & Reitan, 
1974b; Moehle & Fitzhugh-Bell, 1988). Similarly, another study found that the MMPI 
was unable to detect post-operative changes in temporalobectomy patients regardless of 
side of onset (Trenerry, et al., 1996). Highlighting this trend, another study demonstrated 
that measures of personality and measures of neuropsychological constructs may create 
an artificial distinction due to the method variance contained in the MMPI. In other 
words, the reason that the MMPI appears to have an orthogonal, or distinctive structure, 
was based on the method of taking the test and not because an actual, statistical 
difference exists between tests of cognition and tests of personality (Zillmer & Perry,
1996).
This began to illuminate the inherent problem that individuals may endorse items 
on the MMPI-2 representative of cognitive impairment instead of psychopathology 
(Reitan & Wolfson, 1997; Tate, 1999). Bomstein and Kozora (1990) demonstrated that 
the MMPI-2 items were nonspecific to psychiatric or neurological content. In their study,
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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scale 8 was unable to differentiate patients diagnosed with epilepsy from patients 
diagnosed with schizophrenia. Their research amplified once again the inherent problem 
of item nonspecificity that Ayers and colleagues discussed. However, others have found 
evidence that the MMPI is useful in neuropsychological evaluations (Gass, 1991b; 
Larrabee, 2003).
Subsequent studies aimed at associating MMPI variables with neuropsychological 
test variables revealed that the MMPI does contain item content reflective of 
neuropsychological domains. In a series of studies research demonstrated that cognitive 
variables such as attention, memory, speech impairment, information processing speed, 
and cognitive efficiency are associated with certain MMPI elevations (Gass, 1991; Gass, 
1996; Ross, Putnam, Gass, Bailey, & Adams, 2003). Some suggested that, if interpreted 
correctly, the MMPI could offer useful information in the neuropsychological context 
(Gass, 1991b). Researchers continued to pursue approaches that might improve the 
validity of the MMPI in neurological populations. Unlike prior research that focused on 
scale development or decision rules (Russell, 1975; Watson & Thomas, 1968), some 
researchers devised procedures for altering the actual profile by eliminating items from 
the Clinical scales that contain “neurologically related” content (Gass & Russell, 1991). 
Correcting the MMPI-2 for TBI Symptoms
The understanding that items on the MMPI could reflect both neurological and 
psychiatric symptoms led to questioning the appropriateness of the MMPI / MMPI-2 in 
neuropsychological examinations (Cripe, 1996). One approach that attempted to address 
this issue is described as “neurocorrection.” Neurocorrection refers to the process of
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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identifying items that contain neurological content and subsequently deleting those items 
from their respective scales and then replotting the profile. The profile is then said to be 
neurocorrected. Essentially, this method corrects for scale elevations in which items 
could theoretically be endorsed due to neurological symptoms rather than symptoms of 
psychopathology.
Gass and Russell (1991) conducted the first study of neurocorrecting the MMPI 
with patients with head injury. MMPI prorated raw scores were applied to neurological 
items that assigned a new value to the items that were “equivalent to the individual’s ratio 
of non-neurological item endorsement in each scale” (p. 255). By adjusting profiles with 
a weighted score, the raw score can be interpreted in proportion to the original profile.
In a study that attempted to address the limitations of the first, Gass (1991) added 
a control group and derived neurological items in an empirical manner. First, items were 
selected that could reasonably be indicative of head injury. The researchers then gave the 
370 item version MMPI to 75 patients diagnosed with various degrees of brain injury.
The researchers then derived through principal components analysis two factors. Factor 
one consisted of 14 items that accounted for the main source of variance (24%). The 
items reflect somatic and cognitive related content.
This correction of the scales attenuates or suppresses MMPI profiles in patients 
with head injury. Gass (1991) explains that this deflation in the profile more accurately 
reflects the individual's psychiatric status because the scales have been corrected for 
neurological complaints. Interpreting the basic profile becomes more meaningful than the 
attempts at using the instrument as a diagnostic tool. Other researchers have followed
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Gass’s original study and constructed their own neurocorrection scales by using both 
rational and empirical methods. (Alfano, et al., 1993; Artzy, 1996; Van Balen, et al,
1997).
Brulot, Strauss, and Spellacy (1997) tested the validity of the empirical correction 
scales related to injury severity, neuropsychological test performance, and depression.
The authors devised a hybrid scale in which at least two items overlapped from the Gass 
(1991), Alfano et al. (1993), or Artzy (1996) correction scales. There were no 
associations between the correction factors and injury severity as measured by loss of 
consciousness (LOC and post-traumatic amnesia (PTA), and neuropsychological test 
performance overall. In addition, the authors found that the correction factors did 
significantly relate to the MMPI-2 content scale of depression (DEP), suggesting that 
items on this scale may also contribute to content bias as observed in previous studies 
with scale 8.
This finding led the authors to questions the validity of the correction factors as 
reflecting physical and cognitive impairments rather than emotional disturbances. Thus, 
due to the moderate correlations between the DEP scale and the correction scales, the 
nonspecificity of mild head injury symptoms and depression lead to problems in 
differentiating the respective domains of impairment. As in the Edwards et al. (2003) 
study, acute symptoms of TBI reflect more of the physical attributes of impairment, and 
as symptoms persist, somatic and affective symptoms may dominate complaints. 
However, as cognitive symptoms remit, so should symptoms reflecting emotional and 
psychological maladjustment (Gualtiere, 1995).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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In an attempt to validate the neurobehavioral content of Gass's (1991) correction 
scale, Rayls, Mittenberg, Bums, and Theroux (2000) tested Gass’s neurological 
correction scale in patients meeting criteria for mild head trauma. Their results indicated 
that Gass’s items reflect acute mild head trauma sequelae, given that there were no 
significant differences in item endorsement rates for the chronic profiles compared to the 
normative group. As suggested by the authors, one possible explanation for their results 
could be that endorsement of neurologically related items is “related to depression rather 
than cognitive impairment" (p. 549). They go on to add that test-takers may endorse 
items by misattributing item content reflective of emotional maladjustment.
Edwards et al. (2003) administered the full MMPI-2 to a group of 35 patients with 
differing levels of head injury severity. In addition to the head injury sample, a group of 
35 psychiatric patients with no reported history of organic brain syndrome or 
neurological disorder were selected as a comparison group. The psychiatric group 
consisted of patients diagnosed with a variety of affective disorders and substance abuse. 
The authors compared three different correction scales, one of which was developed on 
group of multiple sclerosis patients (Meyerink, Reitan, & Setz, 1988). Results indicated 
that that none of the scales produced significant differences in rates of item 
endorsements. In addition, profile changes led to clinically relevant information for 
interpretive means. Yet the authors acknowledge that correction of the clinical scales may 
lead to psychometrically new scales yet to be validated.
Glassmire et al. (2003) also tested the classification ability of the neurocorrection 
scales from Gass (1991), Alfano et al. (1993), and Gass & Russell (1991). Like other
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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studies, results indicated that the neurocorrection scales demonstrated good ability to 
differentiate head injured patients from normals. However, they failed to demonstrate 
adequate ability to differentiate TBI patients from psychiatric patients.
Studies examining the use of the MMPI-2 in neuropsychological contexts have 
produced inconsistent results (Cripe, 1996). A large body of literature has identified 
additional variables that may influence MMPI-2 scale profiles. These variables may 
prolong cognitive impairment and maintain neuropsychological complaints.
Variables That Moderate MMPI-2 Profiles
Larrabee (1999) discusses several moderating variables that could influence the 
degree of symptom expression indicated on the MMPI-2 profile. Included are injury 
variables such as length PTA, duration of LOC, or the emergence of post-traumatic 
seizures. Persons with mild head injuries reflect a greater deficit or dysfunctional level on 
the MMPI-2 clinical scales than those with more severe head injuries. This is referred to 
as the “paradoxical severity effect” (Youngjohn, Burrows, & Erdal, 1995). The 
phenomenon is amplified even more when individuals are involved in litigation (Binder 
& Rohling, 1996; Hoffman, Scott, Emick, & Adams, 1999; Youngjohn, Davis, & Wolf,
1997). Other variables include subject variables such as age, adverse life events, chronic 
social difficulties, gender, and symptom expression like somatization (Larrabee, 1999). 
TBI Simulation and the MMPI-2 Fake Bad Scale
Historically, clinicians have attributed late effects of mild head injury to 
psychogenic factors or external incentives (Gasquoine, 1998; Strauss & Savitsky, 1934; 
Tate, 1998,2003). In a recent survey of the National Academy of Neuropsychology and
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Division 40 of the American Psychological Association, it was reported that forensic 
referrals make up the second highest reimbursement source in private practice clinical 
neuropsychology (Sweet, Peck, Abramowitz, & Etzweiller, 2003). In addition, referrals 
from attorneys represent the third highest referral source behind psychiatry and 
neurology, respectively (Sweet, Moberg, & Suchy, 2000). It has been demonstrated 
through meta-analyses that the MMPI-2 Validity and malingering scales are sensitive to 
certain forms of psychopathology (Berry, Baer, & Harris, 1991; Graham, et al., 1991; 
Rogers, 2003). However, the validity scales and special malingering scales are not 
specific to head injury or malingering of cognitive impairment (Greiffenstein, Gola, & 
Baker, 1995; Lamb, Berry, Wetter, & Baer, 1994).
In order to address malingering in personal injury contexts, Lees-Haley, English, 
and Glenn (1991) developed a scale specifically for the purpose of detecting exaggerated 
emotional distress. Inspired by Gough's Dissimulation Scale (Ds; Gough, 1947) and 
applied practically based on clinical experience, Lees-Haley and colleagues selected 
items that represented both simulation and dissimulation characteristics. These include 
not only the exaggeration of neurobehavioral symptoms, but also the concealment of 
deviant behavior and presenting oneself in a positive manner. The result of their effort 
was the creation of the Fake Bad Scale and studies have reported the clinical utility of 
detecting exaggeration of complaints related to TBI (Larrabee, 2003; Martens, Donders, 
& Millis, 2001; Ross, Millis, Krukowski, Putnam, & Adams, 2004).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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The FBS consists of 43 items obtained from MMPI responses from personal
injury claimants who “appeared to be clearly malingering” (p. 205). The responses tended
to fit a model that reflected:
“ 1) appearing honest; 2) appearing psychologically normal except for the 
influence of the alleged cause of injury; 3) avoiding admitting preexisting 
psychopathology; 4) attempting to minimize the impact of previously disclosed 
preexisting complaints; 5) minimizing or hiding perjury, antisocial or illegal 
behavior; and 6) presenting a degree of injury or disability within perceived limits 
of plausibility” (Lees-Haley, et al., 1991, p. 204).
Utilizing a cutoff point of 20 on the FBS for all groups, the scale classified 96% of the
malingering group, as opposed to the non-malingering claimants who were correctly
classified at the 90% level. A total accuracy rate of 93% for both groups filing claims was
obtained. For the medical outpatients simulating a motor vehicle accident, toxic exposure,
and job stress, the scale correctly classified 88%, 53%, and 83% respectively. It was clear
that the performance of the FBS initially looked promising for the purpose of detecting
simulated impairment during personal injury evaluations (Lees-Haley, Iverson, Lange,
Fox, & Allen, III, 2002). However, additional studies would call the construct validity of
the FBS into question, sparking a current debate questioning the utility of the FBS in
personal injury examinations (Butcher, Arbisi, Atlis, & McNulty, 2003; Rogers, 2003).
Concerned about the construct validity on the FBS, Butcher et al. (2003)
examined MMPI-2 archival files from 108,791 subjects compiled between 1990 and
1996. Six settings were represented in the analysis, and, when a conservative cutoff of 26
was applied, between 2.4 - 30% of the individuals were classified as malingering. The
authors concluded that the FBS over-predicts malingering despite adjusting cutoff scores
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for differences in setting base rates. Instead, Butcher et al. state that the FBS reflects a 
broad variety of somatic symptoms and is "associated more with the expression of 
psychopathology in which physical symptoms are experienced" (p.482). Butcher and 
colleagues subsequently called for the abandonment of the FBS for detecting somatic 
malingering (Arbisi & Butcher, 2004).
Dearth et al. (2005) used an analog design in which they tested the ability of the 
FBS to classify TBI simulators above and beyond that of the other validity scales 
contained in the MMPI-2. Their results showed that the FBS was superior to the 
traditional validity scales, suggesting a different “operating profile” than the standard F 
family of validity scales, particularly in settings with high base rates of malingering head 
injury.
However, there has only been one study that considered neurocorrection 
procedures as a useful technique in differentiating MMPI profiles between patients 
undergoing a forensic neuropsychological evaluation for head injuries and patients 
involved in a forensic psychological evaluation. Dunn and Lees-Haley (1995) tested the 
effectiveness of the Gass (1991) correction procedure in which 14 items were deleted 
from the standard profile. Results demonstrated that the correction procedure did not 
significantly differentiate persons litigating personal injury or primarily whiplash and 
head injured group profiles. In fact, they reported that only 5 items were significantly 
differentially endorsed by the two groups out of the total 14. They subsequently rescored 
the profiles by only eliminating the five items, again finding nonsignificant mean group
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differences. The authors stated that the Gass correction procedure should therefore not be 
used in forensic neuropsychological examinations.
Purpose o f Current Study
To date, there has been no published research examining the effectiveness of 
MMPI-2 neurological correction scales as indicators of possible simulation of cognitive 
impairment. It is thought that the neurocorrection scales carry a unique “operating 
profile” given their neurologically specific content. Unlike the Dunn and Lees-Haley 
(1995) study, this study utilizes the neurocorrection scales as independent ordinal scales, 
and not a “correction” procedure by eliminating items from the standard profile.
This study examines the ability of each of the published head injury neurocorrection 
scales to differentiate TBI simulators and student controls. It utilizes a comparison group 
of archival patients with documented mild to moderate head injury to test if the scales can 
differentiate between TBI simulators and community TBI patients.
However, the main purpose of the current study is to compare the most effective 
neurocorrection scale against the Fake Bad Scale in a simulated TBI malingering 
paradigm. If the hypotheses are correct, this study will provide grounds for further 
investigation on the clinical utility of the neurocorrection scales beyond profile analysis.
It could also call into question the use of the MMPI-2 in forensic neuropsychological 
examinations. Specifically, it will draw attention to the practice of using self-report 
inventories developed on psychiatric patients for assessment with neuropsychological 
populations.
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Hypotheses
The first hypothesis concerns the ability of the neurocorrection scales to 
differentiate TBI simulators from controls effectively. Although the Gass (1991) scale 
has the most published research focused on its sensitivity to head injury, this study will 
instead predict that the Van Balen et al. (1997) scale will be able to predict simulators of 
cognitive impairment above the other scales. This hypothesis is based on the premise that 
the scale is derived from the complete MMPI-2 item set, compared to the 370-item 
version of the Gass (1991), and Gass and Russell (1991) scales. The scale also reflects 
item content that was endorsed by at least two professionals from the field of neurology, 
neuropsychology, psychiatry, and physiatry as pertaining to head injury sequelae. Thus, 
individuals who intend to express cognitive impairment might endorse items that, on the 
surface, reflect cognitive content consistent with bona fide mild head injury (Huskey, 
2004) and, popular misconceptions of head injury symptoms (Guilmette & Paglia, 2004; 
Swift & Wilson, 2001).
The second hypothesis concerns the effectiveness of the correction scale(s) when 
compared to the Fake Bad Scale. It is predicted that the most effective neurocorrection 
scale will outperform the Fake Bad Scale in the ability to differentiate effectively TBI 
simulators from actual TBI patients. This prediction is based on the premise that the 
neurocorrection scale will be more likely to detect cognitive symptomatology, as opposed 
to the FBS, which was developed to detect emotional and somatic distress (Lees-Haley, 
et al., 1991).
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Method
Participants
University of Montana undergraduate psychology students were recruited during 
the spring and summer sessions of the year 2005. Sixty students were randomly assigned 
to either a TBI simulation or control group. Students were allowed to participate if they 
were 18 years of age or older and current psychology students at The University of 
Montana. The 60 students received 3 credits toward their respective courses for 
participation. Student information sheets were then screened and protocols excluded from 
the final analysis if participants endorsed a history of neurological or psychiatric 
treatment. Specifically, students were eliminated if  they reported a history of any mood 
related disorder, anxiety condition, substance abuse, Attention Deficit Hyperactivity 
Disorder (ADHD) migraine headache, a seizure condition, or a mild to moderate head 
injury. After screening, the sample included 15 students in the TBI simulation group and 
17 students in the control condition. Every other student was assigned to the TBI 
simulation group until 30 participants for each group completed the MMPI-2.
Thirty archival files from community TBI patients were also collected. The same 
inclusion criteria applied for this group, age 18 years or older and a completed full 
MMPI-2. Additionally, informed consent must have been documented in their records 
and have met the clinical criteria for a mild to moderate head injury. The sample was 
taken from records between the years 2002-2005. After screening for the prior 
neurological and psychiatric conditions mentioned above, the inclusive sample served as 
a clinical comparison group (n = 22).
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Determining the Severity o f Head Injury
The severity of head injury was defined according to one of three possible injury 
variables (see appendix D). Measures of injury severity consisted of the length of time 
one experienced a loss of consciousness (LOC) due to a blow the head, length of time 
one experienced post-traumatic amnesia (PTA), or score on the Glascow Coma Scale 
(GCS; Williamson, Scott, & Adams, 1996). For mild head injury, the criteria consist of a) 
LOC for less than 20 minutes, b) PTA of less than 24 hours, and c) GCS of 13-15. For 
moderate head injury, the criteria consist of either a) LOC of 20 minutes - 36 hours, b) 
PTA of 1-7 days, and c) GCS of 9-12 (DeKruijk, Twijnstra, & Leffers, 2001). An 
individual was required to have met one of the criteria to be included in the current study. 
Materials
The 567-item version of the MMPI-2 was administered or collected from each 
participant. Validity and Clinical scale raw scores were transformed into uniform T - 
scores for validity and K-corrected Clinical scales. Raw scores from five neurocorrection 
scales and the Fake Bad Scale were also computed.
MMPI-2 Validity Scales
The validity scales included the family of F scales typically used to identify over­
reporting of psychiatric symptoms. The scales included the F (Infrequency) scale, which 
measures the frequency of items that are symptoms rarely experienced by psychiatric 
patients; F(b) - Back Infrequency, which consists of items of infrequent psychiatric 
symptoms for the last half of the MMPI-2; and F(p) - Infrequency Psychopathology 
(Arbisi & Ben-Porath, 1995), which is a measure of infrequent symptoms endorsed by no
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more than 20% of a sample of psychiatric inpatients. Two other validity scales that 
measure under-reporting of psychopathology were included. The Lie scale (L) is a 
measure of defensiveness defined as a refusal to admit even minor faults, and the 
correction scale (K) which is a measure of subtle or sophisticated attempts to present 
oneself favorably (Meehl & Hathaway, 1946).
Finally, consistency of item endorsement was measured by including the Variable 
Response Inconsistency (VRIN) scale and the True Response Inconsistency (TRIN) scale 
(Butcher, et al., 1989). The VRIN scale consists of 67 pairs of items that have similar or 
opposite item content. The TRIN scale measures whether the respondent answered the 
item pairs as either “true” or “false” (Greene, 2000).
MMPI-2 Clinical Scales
The ten clinical scales, in order, are contemporarily referred to by their numerical 
codes. These are Scale 1 -  Hypochondriasis, 2 - Depression, 3 - Hysteria, 4 - 
Psychopathic Deviate, 5 - Masculinity/Femininity, 6 - Paranoia, 7 - Psychasthenia, 8 - 
Schizophrenia, 9 - Hypomania, and 0 - Social Introversion.
Scale 1 reflects a wide variety of nonspecific somatic concerns. Somatic areas 
include complaints regarding the abdomen and back, and persist despite negative medical 
evidence. It must be noted that individuals who are actually ill will obtain moderate 
elevations. High scorers on this scale, if physically ill, will also tend to have 
hypochondriacal features associated with their illness (Greene, 2000). Personality traits 
often include self-centeredness, demandingness, cynicism, and stubbornness 
(deMendonca, et al., 1984).
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Scale 2 is characterized as a diverse scale that includes features of poor morale, 
worry, self-punishing, hopelessness about the future, and dissatisfaction with one’s life 
(deMendonca, et al., 1984; Graham, 2000). There are also items that reflect physical 
symptoms, such as sleeplessness and gastrointestinal problems. The scale also includes 
content related to apathy, psychological sensitivity, and social withdrawal. Greene (2000) 
states that scale 2 is a difficult scale to interpret in isolation given its many factors.
Scale 3 was developed on patients either diagnosed with Hysteria with what 
currently be called Histrionic Personality Disorder. Item content reflects somatic 
symptoms in the head, arms, and legs, as well as a perception of social adjustment. 
Persons with high scores on this scale are friendly, self-centered, demanding, immature, 
and suggestible (deMondonca, et al., 1984) and only avoid responsibility and develop 
conversion symptoms when under overwhelming stress (Greene, 2000).
Scale 4 was developed on young adults who were diagnosed with a “psychopathic 
personality” (McKinley & Hathaway, 1946). The scale typically represents social 
maladjustment and a lack of pleasant experiences. Poor impulse control, emotional 
shallowness, a disregard for social conventions, and hostility towards authority figures 
are features that describe high scorers.
Scale 5 measures gender stereotypes and was developed to detect potential 
homosexual trends when homosexuality was once considered a psychiatric disorder by 
the American Psychiatric Association (APA) as indicated in the second edition of the . 
Diagnostic and Statistical Manual of Mental Disorders (DSM-II, see APA, 1968). This 
scale is not considered a “clinical” scale and will not be included in the analysis.
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Scale 6 represents item content reflective of interpersonal sensitivity, self- 
righteousness, and suspiciousness (deMondonca, et al., 1984). The scale does not 
represent pure cases of paranoid individuals, but rather individuals who were deemed to 
be in a paranoid state, including persons diagnosed with “paranoid schizophrenia” or with 
a “paranoid condition” (Greene, 2000, p. 155).
Scale 7 is generally considered a measure of psychological discomfort and 
turmoil, with high scorers often experiencing obsessive thinking and serious levels of 
insecurity (Graham, 2000). The condition of “psychasthenia” is contemporarily 
conceptualized as obsessive-compulsive disorder. But rather than tapping specific 
behaviors or rituals, the scale reflects personality characteristics such as interpersonal 
sensitivity, neuroticism, anxiety, and social withdrawal, as well as poor physical health 
(deMondonca, et al., 1984; Graham, 2000).
Scale 8 reflects the most diverse Clinical scale given its seven factors. The scale 
taps a wide variety of symptoms that include “paranoia, concern about sex, sensitivity to 
rejection, psychotic tendencies, poor concentration, poor health, and social withdrawal” 
(Graham, 2000). Additional characteristics include confusion, worry, imaginativeness, 
unconventional attitudes, and impulsiveness (deMondonca, et al, 1984). Not only can 
high scoring protocols be related to the above variables, elevations will also be produced 
by individuals with neurological impairment such as epilepsy (Bomstein & Kozora,
1995).
Scale 9 was derived from psychiatric patients who demonstrated characteristics of 
hypomania. Hypomania is characterized on the MMPI-2 as disturbances in “activity
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level, excitability, irritability, and grandiosity” (Graham, 2000, p. 82). Specifically, high 
scorers endorse items that describe accelerated psychomotor behavior and speech, 
irritable and depressed mood, and flight of ideas. The scale is sensitive to the effects of 
age, with elderly populations often producing scores below average, and ethnicity, with 
American Indian/Alaska Native, Hispanic, and African-American groups scoring on 
average higher than Caucasians (p. 82). High scorers on this scale are typically viewed as 
having excessive energy and a tendency to manifest an unrealistic self-appraisal.
The study will also include scale 0 although this scale was not developed on a 
particular patient group. Rather, it was developed to represent the continuum of 
personality traits of social introversion -  extroversion. The scale should not be interpreted 
in isolation due to its development on university students, but it can provide useful 
information when additional scale elevations are observed (Graham, 2000).
Five MMPI-2 Neurocorrection Scales
Five neurocorrection scales were used in this study. Three of the scales were 
derived through empirical methods and two were developed from a rational approach.
The Gass (1991) 14-item scale comprises items that were derived through Principle 
Components Analysis. The oblique rotation yielded a two factor solution for the 370-item 
version of the inventory. The first factor included 28.4% of the overall variance and was 
labeled “neurological complaints” (p. 29). The items represented neurological symptoms 
of cognitive inefficiency, muscle weakness, tremor, and speech related content.
The Alfano et al. (1993) 13-item scale was also derived through Principle 
Components Analysis but the analysis was conducted on the full 566-item MMPI. This
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scale accounted for 25% of the overall variance and was labeled a “neurobehavioral” 
factor. The items contained neurological symptom complaints related to poor attention, 
sensory and motor dysfunction, or problems with psychosocial adjustment such as 
vocation or with sexual satisfaction.
The Artzy (1996) 17-item TBI scale was another scale in which Principle 
Components Analysis was used to derive a head injury factor. Artzy compared patients 
with head injuries to patients with chronic pain. The subsequent TBI factor accounted for 
28.5% of the overall variance and represented item content such as dizziness, attention 
and concentration problems, and poor psychosocial adjustment.
The rationally derived Gass and Russell (1991) 42-item scale predated the 
aforementioned Gass (1991) study. An innovative approach was used instead of the 
empirical method. The authors had professionals in the field of neurology select items 
that could possibly represent common “physical, not emotional” sequelae for brain 
damage (p. 255). This approach of using professionals to select items based on their 
content and clinical representation of symptoms is referred to as a rational method. The 
neurological items in this scale are represented in the MMPI-2 Harris-Lingoes subscales 
(Gass & Russell, 1991).
Instead of adopting the usual procedure of deleting the items from the profile, 
Gass and Russell assigned a weighted score to neurological related items. The weighted 
scores were based on the ratio of non-neurologically related items that were endorsed in 
each Clinical scale. The weighted scores were entered into the overall scoring of each
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scale. The Clinical scales were then K-corrected. This procedure allowed for scale 
adjustment without the potential psychometric pitfalls associated with item deletion.
Finally, the Van Balen et al. (1997) 22-item scale was also derived through 
rational methods. Forty experts from four professions that commonly treat patients with 
central nervous system (CNS) related impairments were asked to imagine patients with 
CNS dysfunction in general and identify items that could possibly reflect common 
symptoms. Then, the judges were asked to do the same with 3 major patient groups, 
namely “TBI, stroke, and whiplash” (p. 358). The items that obtained inter-rater 
agreement levels of 70% or higher and were endorsed by at least two different 
professions were selected as indicative of a particular patient population.
Procedure
Each student was given instructions in a private room by a trained research 
assistant. Participants assigned to the control group received standard instructions as 
indicated in the MMPI-2 clinical manual (Butcher, et al., 1989). Participants assigned to 
the TBI simulator group were provided with instructions in which participants were 
instructed to simulate a mild to moderate head injury (see appendix F). Participants in the 
TBI simulator group were also told to imagine that they had experienced a head injury in 
a motor vehicle accident. Additionally, TBI simulators were to take the MMPI-2 as part 
of the legal process for obtaining maximum financial compensation for their injuries. 
Finally, even though their injuries were to have diminished, they were to answer the 
questions from the MMPI-2 in a manner that suggested they were continuing to 
experience the effects of a head injury. As a measure of response set, student TBI
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simulators were asked if they put forth maximum effort to simulate symptoms of a head 
injury. All student participants received the allotted credit regardless of their ability to 
simulate a head injury. Completed MMPI-2 protocols were obtained on the community 
TBI group where informed consent to participate in research had been documented in 
their clinical record.
Analysis o f the Data
In order to examine the utility of the neurocorrection scales as possible indicators 
of TBI simulation, a series of data analyses were conducted to answer the following 
research questions:
1) Can MMPI-2 neurocorrection scales detect simulated cognitive impairment in 
a compensation seeking paradigm?
2) Can MMPI-2 neurocorrection scales differentiate between groups of analog 
TBI malingerers, actual TBI patients, and controls?
3) Can MMPI-2 neurocorrection scales classify group membership equal to or 
better than the Fake Bad Scale?
Data procedures involved generating descriptive statistics for demographic 
variables age, years of education, gender, and ethnicity. Means, standard deviations, and 
results from one-way analysis of variance (ANOVA) and the Tukey honestly significant 
difference (HSD) test were computed to detect group differences on MMPI-2 Validity 
and Clinical scales (see appendix H-I). ANOVA, Tukey’s HSD, and overall measure of 
association expressed as eta-squared (q2) for neurocorrection scales were also conducted 
to ascertain group mean differences.
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Effect Size Contrasts o f Neurocorrection Scales
In order to answer the question of whether the neurocorrection scales could 
differentiate between the three groups, a series of pairwise effect size contrasts were 
conducted. The first contrast determined what neurocorrection scale was clinically 
sensitive to TBI simulation, as well as meeting the selection criteria for entry into the 
classification analysis. The next two contrasts answer the research questions regarding 
whether the neurocorrection scales could differentiate community TBI patients and 
controls, and TBI simulators and community TBI patients. In order to measure the 
magnitude of separation, a converted Cohen’s d  effect size statistic was calculated with 
pooled standard deviations based on unequal group sizes (Zakzanis, 2001).
Cohen’s d  is the estimated difference between the target and non-target group 
means calibrated in pooled standard deviation units (Cohen, 1988). This statistic has been 
deemed the most appropriate measure of effect size because it does not assume 
homogeneity of variances among groups, and is calculated independently of sample size. 
Zakzanis’ (2001) approach converts standard Cohen’s d  statistics to display the degree of 
test score overlap between the two groups being compared by subtracting the amount of 
test score nonoverlap from 100. Percentages of test score overlap between the groups can 
be contrasted with effect sizes, and it ranges from 0-4. A converted effect size of 0 would 
be interpreted as “no effect” and an effect size of 4 would represent “absolute 
discriminability” (Zakzanis, 2001, p.658).
This study used the clinical significance marker of 3.0, which converts to 7% 
overlap between groups on a particular test measure. This implies that 93% of the target
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group participants actually produced test scores that were not produced by non-target 
group members (Zakzanis, 2001). Calculation of effect sizes using pooled standard 
deviations for unequal group sizes were used to answer research questions one and two. 
Classification Analysis
Binary logistic regression analyses was conducted to answer question three 
regarding the ability of the best neurocorrection scale(s) to classify TBI simulators 
compared to the FBS. Logistic regression does not assume homogeneity of variance 
among groups and is based on the odds that a random score on a given measure will be 
classified as in the target category (Grim & Yamold, 2001).
In this analysis, the best neurocorrection scale and the FBS were the independent 
variables, while group membership was the dependent variable. The analysis generated 
odds ratios that represented the likelihood a random participant’s score would be 
classified as coming from the target group. Unstandardized regression coefficients (B) 
represented the nonlinear transformation of the predictor for a binary or dichotomous 
dependent variable (Cohen et al., 2004). Since this study was aimed at determining the 
effectiveness of the neurocorrection scales to detect TBI simulation, the target group for 
the analysis was the TBI simulator group.
Operating Statistics
Sensitivity, specificity, and overall correct classification percentages were 
conducted for the best neurocorrection scale and the FBS. Sensitivity refers to the 
percentage correctly classified target group members. Specificity is the percentage of
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correctly classified non-target members. Hit rate refers to the overall correct classification 
percentages, a combination of sensitivity and specificity rates.
Results
Results o f  Demographic Variables
Table 1 displays group means for age and years of education. Significant age 
differences were observed among groups, [F(l ,  54) = 31.7, p <  .001, r\2= .55]. Tukey’s 
HSD test revealed that the TBI simulator and control groups were significantly younger 
than the community TBI group. However, there were no significant differences found 
between the TBI simulator and control groups. There were no significant differences in 
years of education across groups, [F (2, 54) = .03,p  = .97, D2= 01]. Out of the 15 TBI 
simulators, 100% stated that they put forth maximum effort while simulating a head 
injury.
Table 2 presents gender and ethnic composition of each group. Gender 
composition did not differ significantly across groups, y2 (2) = .04, p  = .98. Essentially 
each group had identical female-to-male percentages. All groups were approximately 
two-thirds female with just over one-third male. The total sample composition was 65%
female and 35% males. Additionally, there were no significant differences in ethnic
•  • 2 •composition across groups, % (6) = 5.9,p  = .43. The TBI simulator group was 100%
Caucasian, controls 91% Caucasian, and the community TBI group approximately 94% 
Caucasian.
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Analysis o f  Variance Comparing Groups on MMPI-2 Neurocorrection Scales
Analysis of variance procedures were computed for the neurocorrection scales 
across groups. All scales produced significant mean differences and are displayed in 
Table 5.
Significant mean differences were observed on the Gass (1991) scale, [F (2, 54) = 
34.1,p  < .05, r|2= .57]. Tukey’s HSD revealed significant differences between both TBI 
simulators and community TBI patients compared to controls,/) < .05. No significant 
differences were observed between the TBI simulators and community TBI patients.
Significant differences among the 3 groups were observed on the Alfano scale, [A 
(2, 54) = 28.1 ,p  < .05, r|2-  .53]. Both TBI simulators and community patients differed 
from controls,/? < .05, but not between the simulator and TBI patient groups.
The Artzy scale revealed significant group mean differences, [F (2, 54) = 13.7,p  
< .05, r| = .35]. TBI simulators differed significantly from controls and community TBI 
patients,/? < .05, but did not differ between community TBI patients and controls.
The Gass and Russell (1991) scale revealed significant differences among groups, 
[A (2, 54) = 27.3,/? < .05, rj2 = .52]. Both TBI simulators and community patients differed 
from controls,/? < .05, but did not differ between each other.
The Van Balen scale also revealed significant mean differences among the 3 
groups, [A (2, 54) = 33.3, p  < .05, r\2 = .57]. Tukey’s HSD revealed the TBI simulators 
differed significantly from control subjects, p < .05, but not from community TBI 
patients. Similarly, community TBI patients differed from controls,/? < .05, but not TBI 
simulators.
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The FBS was also included in a one-way ANOVA procedure. The FBS produced 
significant differences among groups, [F (2, 54) = 20.3, p  < .05, r\2 = .44]. It was the 
only validity scale that did not produce significant differences among scores for the TBI 
simulators and the community TBI group. However, both TBI simulators and community 
TBI patients did differ from controls,/) < .05.
A description of group differences on the Basic scales can be in the appendix H. 
The Validity scales demonstrated significant group differences on the family of 
Infrequency scales (see appendix I). The typical profile on the MMPI-2 Clinical scales 
for patients with mild head injury, and involved in compensation litigation, was 
replicated in this study (see appendix J).
Differential Ability o f the Neurocorrection Scales
In order to address the question regarding using the neurocorrection scales to 
differentiate between TBI simulators and controls, a pairwise effect size contrast utilizing 
a converted Cohen’s d  effect size estimate based on unequal group sizes was calculated 
for each scale (see Table 6). The results indicate that Alfano’s scale produced the only 
effect size to reach the clinical significance marker of 3.0 (d = 3.3). The large effect size 
indicated a 4% overlap between neurocorrection scores between the two groups.
All of the remaining neurocorrection scales produced moderate effects. The Gass 
scale produced a moderate effect size of d -  2.9, indicating a 7.0 % test score overlap. 
Artzy’s scale produced a moderate effect size of d=  2.0, indicating 18.9% overlap among 
scores between the two groups. The Gass and Russell scale also yielded a moderate effect 
size (d = 2.7) that indicates 9.5% test score overlap. The Van Balen scale produced an
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effect size in the moderate range (d=  2.8) that translates into an 8.8% overlap in group 
scores.
In order to examine whether the neurocorrection scales are able to differentiate 
between community TBI patients and controls, a second series of effect size contrasts 
were conducted (see Table 6). Results indicated that there were no clinically significant 
effect size estimates produced by the scores. Gass and Russell’s scale obtained a 
moderate effect size (d=  2.4) with 13% scale score overlap. Van Balen’s scale also 
produced a moderate effect size (d= 2.3) that translates into 17.1% test score overlap.
The Gass scale also produced a moderate effect size, (<7 = 2.4), indicating 15.7% score 
overlap. The Alfano scale and the Artzy scale produced small and no effects (d ’s = 1.5 
and .50, respectively).
A final contrast was conducted in order to examine the ability of the 
neurocorrection scales to differentiate TBI simulators from community TBI patients. 
Results revealed that most neurocorrection scales produced trivial effect sizes between 
group scores. The exception was the small effect size produced by Artzy’s scale (d=  1.3), 
which represents 34.7% of overlap between group scores on this scale (see Table 6).
In order to be included in the analysis comparing the classification ability against 
the FBS, neurocorrection scales must have met or exceeded the clinical significance 
marker for effect sizes (3.0; Zakzanis, 2001). The Alfano scale was the only scale to 
reach clinical significance, d  = 3.3. Therefore, the Alfano scale was selected as the only 
neurocorrection scale to be compared to the FBS in the classification analyses.
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Classification Results o f Logistic Regression Analyses
Table 7 displays two separate binary logistic regression procedures examining the 
classification ability of the Alfano neurocorrection scale and FBS. Results from logistic 
regression revealed TBI simulators were .21 times more likely to classified as simulators
' j
than controls using the Alfano scale, Wald % (1, 32) = 4.3, p = .04. The second logistic 
regression procedure examining the FBS revealed that TBI simulators were .56 times
' j
more likely to be classified as a simulator than a controls, Wald % (1, 32) = 8.8, p = .003.
Table 8 displays frequency counts for observed and predicted group membership. 
The Alfano scale correctly classified 13 of 15 TBI simulators and 16 of 17 control 
subjects. The FBS correctly classified 11 of 15 TBI simulators and 14 out of 17 controls. 
Effect Size Comparison Between Alfano and the FBS
Table 9 presents Cohen’s d  effect size contrast for the FBS examining the degree 
of test score overlap compared to the Alfano scale. The FBS produced a small effect size 
of 1.8 which translates into a 22.6% test score overlap. In other words, 22.6% of scores 
on the FBS were shared among both groups, compared to approximately 5% overlap on 
the Alfano scale. All of the neurocorrection scales produced effect sizes larger than the 
FBS when differentiating TBI simulators from controls.
Sensitivity, Specificity, and Overall Hit Rate
Table 10 displays the sensitivity, specificity, and overall correct classification 
rates of both scales while using cutoff scores based on their harmonic means. The Alfano 
scale classified 86.7% of the TBI simulators correctly while classifying 94.1% of the 
control subjects correctly for an overall hit rate of 90.6%. Comparatively, the FBS
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classified 78.3% of the TBI simulators while classifying 82.4% of the control subjects for 
an overall hit rate of 78.1%. Both scales were able to classify control participants at a 
higher rate than TBI simulators.
Discussion
Performance o f  Neurocorrection Scales Compared to the FBS
Previous research has focused on the FBS as a measure of exaggeration on the 
MMPI-2 in neuropsychological evaluations. This study provides the first evidence 
suggesting that the MMPI-2 neurocorrection scales are superior to the FBS as measures 
of TBI simulation. In fact, all of the neurocorrection scales produced effect sizes larger 
than the FBS. This substantiates the research hypothesis that the neurocorrection scales 
would be more sensitive to head injury simulation than the FBS. A major impetus for 
testing this hypothesis is due to the scales design for identification of cognitive 
complaints. This study hypothesized that the neurocorrection scales would perform as 
good as or better than the FBS, which is designed to detect somatic and emotional 
exaggeration.
Measures taken to improve both internal and external validity included using 
homogenous groups in which prior histories of neurological and psychiatric conditions 
were excluded, as well as adding a comparison group of community patients with 
documented mild to moderate head injury as a comparison group. The instructions for the 
simulator group were purposely left symptomatically ambiguous in order to limit the 
degree of “coaching” provided to TBI simulators. In addition, effect size contrasts were
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employed in order to compensate for high degrees of score variability between the 
simulator, TBI, and control groups, as well as unequal group sizes (Zakzanis, 2001).
Artzy’s scale produced a small effect size differentiating TBI simulators from 
community TBI patients. However, the 35% overlap of scores is unacceptable in clinical 
practice. On a side note, the FBS produced an effect size that translated into 
approximately 66% score overlap between these two groups. The latter result is 
consistent with previous studies in that the FBS largely over-estimates malingering of 
neurological symptoms (Butcher et al., 2003).
The Influence o f  Prior Probabilities and Base Rates
One important feature of classification studies is the prior probability rates for 
identifying a certain condition. Prior probabilities are based on base rates, or the 
likelihood that any given individual will be classified with a specified condition in a 
particular setting. It has been demonstrated that differences in base rate percentages 
across settings can influence the sensitivity and specificity rates of classification.
The current study had a base rate of malingering of 28%. This is well within the 
reported range of 15% - 40% base rates reported in previous studies (Binder & Willis, 
1991; Fox, et al., 1995; Lees-Haley & Brown, 1993; Mittenberg, et al., 2002). Overall 
correct classification of 78% for the FBS in the current study was slightly higher than the 
Dearth et al. (2005) study in which the FBS achieved an overall hit rate of 73%. It was 
also similar to the Butcher et al. (2003) study that found up to 30% over-prediction of 
malingering by the FBS.
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Previous studies on the FBS have also reported classification results considering 
alternative cutoff scores and base rates. The contrast in this study between simulators and 
controls utilized a cutoff of 7 for the Alfano and 18 for the FBS. When the cutoff scores 
were adjusted for the Alfano scale to 8 and 10, the result was a higher rate of classifying 
control subjects; however, the sensitivity to malingering was lowered. This result is 
attributable to the fact that 3 of the simulators produced scores of 7 or below on this 
scale. Therefore, the elevation of the cutoff score did nothing to improve the sensitivity to 
TBI, only improving the identification of non-brain injured subjects.
Similarly, previous studies have suggested cutoff scores between 21 and 26 for 
the FBS. In the current study, a cutoff of 18 was used in the analog malingerers and 
control contrast that produced the most effective classification levels. In fact, the mean of 
18 for the simulator group was actually lower than the mean of 21 for the TBI group.
This finding is consistent with previous studies in that the FBS appears to be capturing 
item content related to somatic and emotional maladjustment rather than cognitive 
impairment. Consequently, when used to differentiate groups of malingerers from actual 
TBI patients, the FBS will tend to classify those individuals with bona fide TBI as 
malingerers.
This finding is somewhat expected, given the instructions of the current scenario 
referred to being “knocked out and dazed” rather than suggesting specific emotional and 
physical symptoms. Research on common misconceptions of brain injury symptoms by 
the general public and neurological patients consistently finds that that people tend to 
overestimate the degree of injury related to mild head injuries as well as overestimate
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premorbid psychological health and cognitive ability (Coolidge, et al., 1998; Mittenberg, 
et al., 1991; Williams, et al., 1998). In addition, it remains a diagnostic dilemma that 
post-concussive symptoms are not specific to mild head injuries and have been reported 
to occur in the general population at rates as high as 75% within a two week period 
(Iverson & Lange, 2003).
Performance o f  MMPI-2 Validity Scales
Considering the performance of the MMPI-2 Basic scales, the family of F scales 
surprisingly, differentiated TBI simulators from controls and community TBI patients. 
Like the Dearth et al. (2005) study, the F scale may indeed show promise in detecting 
simulated TBI. Perhaps it would have outperformed the FBS in this study given that the 
mean score of community TBI patients exceeded the TBI simulators on the FBS, but 
were not significantly different.
Performance o f  MMPI-2 Clinical Scales
The pattern of elevation on the Clinical scales was generally consistent with 
previous research in the area. In addition to the well documented elevations on scales 1,
2, 3, 6, 7, and 8. Additional differences were observed on scale 0. MMPI-2 Clinical 
scales 6 and 8 obtained significant differences among all three groups. These results are 
generally consistent with previous research examining MMPI scores with groups of 
analog cognitive malingers and persons involved in financially compensable litigation for 
head injuries (Berry, et al., 1995; Heaton, et al., 1978; Larrabee, 2003; Ross, et al., 2004).
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Applications o f  Neurocorrection Scales for Clinical Practice
The clinical practice of evaluating individuals who might be suspected of 
malingering in neuropsychological contexts involves a multidimensional procedure that 
utilizes tests that have been validated for this purpose (Iverson & Binder, 2000). The 
MMPI-2 is most often used in these circumstances to enhance clinician sensitivity for 
individuals who may exaggerate their cognitive complaints. The neurocorrection scales 
may offer an improved method of detecting cognitive exaggeration.
Considering the neurocorrection scales and their ability to differentiate between 
TBI simulators and community TBI patients, the Artzy scale produced a clinically small 
effect. Approximately 35% of the scores on this scale were produced by both TBI 
patients and the simulators. Although this figure is unacceptable in clinical practice, it is 
approximately half the percentage than the overlap generated by the FBS (66%). 
However, more research needs to be directed at validating the neurocorrection scales as 
measures of cognitive exaggeration.
Limitations o f the Current Study
There are a number of limitations associated with the current study. Due to the 
small sample size, it is possible that if there were additional participants, results would 
have produced coefficients that were more robust and not subject to variability due to low 
power. This may have proven that more than just one neurocorrection scale would have 
demonstrated clinically significant effect sizes for comparison against the FBS.
This study also employed the use of research credits as an incentive that were part 
of the course requirements in which the students were recruited. A more realistic
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monetary incentive such as those used by Dearth et al. (2005) may have produced better 
over-reporting response sets by the simulator group. Using archived records dating 2-3 
years prior to the study may have also influenced test scores. Using a randomized design 
for the TBI group at the time of evaluation, additional screening measures, and 
temporally consistent data would decrease threats to internal validity.
There are also inherent weaknesses with using analog designs compared to 
known- group designs. The primary feature limiting the generalizability of analog studies 
is the inability to simulate real-world forensic contexts. On the other hand, analog studies 
can, by randomization, exert a certain degree of control over experimental variables 
(Rogers, 1997).
Implications fo r  Future Research
This study was limited by a number of factors; however, some significant and 
interesting findings did emerge and are worthy of further examination. The 
neurocorrection scales outperformed the FBS in the TBI simulator versus control 
contrast. This is the first study to look at the effectiveness of these scales for this 
particular purpose and, as a result, preliminary evidence suggests that the scales may 
improve the state of affairs when attempting to identify TBI simulation rather than the 
FBS. It also appears that the neurocorrection scales contain a different operating profile 
compared to the FBS, which captures a different set of symptoms and deceptive strategies 
rather than just simulation of cognitive impairment.
This study suggests it may be more prudent to employ neurocorrection scales in 
lieu of the FBS for patients who complain of late effects of mild head injury. Results
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from the current study suggest that at least one, if not a few of the neurocorrection scales, 
may offer clinical utility in differentiating TBI simulators in forensic contexts. Future 
studies might focus on adding comparison groups in addition to TBI, as well as employ 
scenarios involving different levels of information provided to participants about TBI 
sequelae.
For example, depression and emotional dysregulation become more salient as TBI 
symptoms persist (Reitan & Wolfson, 1997). This information would likely influence the 
sensitivity of the neurocorrection scales given their strict cognitive content. In addition, 
using known-groups of probable malingerers would also provide interesting evidence of 
the head-to-head comparability of the scales under real-world forensic contexts.
Lees-Haley, Iverson, Lange, Fox, and Allen (2002) explicitly state that the 
MMPI-2 does not meet the criteria for legal admissibility of psychological tests regarding 
neurological patients because it does not measure brain injury. This study perhaps 
provides further evidence that the use of the MMPI-2 as an indicator of malingering in 
forensic neuropsychological evaluation must be further explored. As Arbisi and Ben- 
Porath (2003) suggest, accurate normative studies aimed at cross-validating the 
neurocorrection scales with the content and component scales of the MMPI-2 rather than 
the clinical scales are needed. With the introduction of the MMPI-2 Restructured Clinical 
(RC) scales and the common factor of “Demoralization” represented in scale D 
(Tellegan, et al., 2003), another opportunity exists to examine profiles of patients with 
various types of neurological compromise.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
40
Perhaps the most important question not yet investigated is, if one is using the 
MMPI-2 in a forensic neuropsychological evaluation, how much weight should be placed 
on it as a measure o f TBI simulation? Perhaps it is in the best interest of the field of 
psychological assessment to continue to pursue the answer to this question. It may also be 
prudent to continue to examine novel and innovative strategies to detect cognitive 
malingering. Perhaps the self-report format is too susceptible to deceptive responding, 
particularly if the measure has items that are not specific to neurological conditions. It is 
in this spirit that future studies evaluating the MMPI-2 in forensic neuropsychological 
contexts consider using the various neurocorrection scales as indicators of TBI 
simulation.
The current study suggests that there may be an alternative to the FBS in forensic 
neuropsychological evaluations that employ the MMPI-2. It also demonstrated that the 
neurocorrection scales do not meet standards that would consider them as valid measures 
of cognitive malingering. In fact, the problem of symptom nonspecificity still remains, 
even with the narrow neurocorrection scales. The item bias problem remains and calls 
into question the clinical utility of the MMPI-2 as a measure of neuropsychological 
exaggeration in forensic evaluations.
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Table 1
Age and years o f education for three groups.
TBI Simulators Student controls TBI
Variable Mean SD Mean SD Mean SD
Age 21.6a 5.3 20.7a 3.3 40.9b 13.1
Education 12.8 3.1 13 2.8 13.23 1.96
Note: Means that do not share subscripts differ significantly at p = .05 
level. Education represented in years.
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Table 2
Gender and ethnic composition for three groups.
TBI Simulators Student controls TBI
Frequency % Frequency % Frequency %
Gender
Male 5 33.3 6 35.3 8 36.4
Female 10 66.7 11 64.7 14 63.6
Ethnicity
Caucasian 15 100 14 82.4 20 91
American
Indian 0 0 1 5.9 2 9.1
African
American 0 0 1 5.9 0 0
Hispanic 0 0 1 5.9 0 0
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Table 3
Analysis o f variance comparing groups on MMPI-2 neurocorrection scales and the FBS.
TBI simulators Student controls TBI ANOVA
(«=15) (n~17) («=22)
Scale n Mean SD Mean SD Mean SD F (2, 54)
Gass 14 10.3. 3.7 2.1b 1.8 7.5a 3.0 34.1* .57
Alfano 13 9 .7 . 1.9 3.4b 1.9 7.1a 3.0 28.1* .53
Artzy 17 11-la 2.2 6.4b 2.5 7.7b 3.0 13.7* .35
Gass & 
Russell 42 23 .5 . 4.9 12.4b 3.4 2 1 .5 . 5.2 27.3* .52
Van Balen 22 12.9. 3.5 3.9b 3.1 13.5. 4.7 33.3* .57
FBS 43 18.4. 3.7 11.7b 3.6 21.0, 6.0 20.3* .44
Note: n - number of items contained within each scale, if-  eta-squared measure of effect size. 
Means and standard deviations derived from raw scores. Means in the same row that do not share 
subscripts differ significantly in the Tukey HSD comparison, * p < .05.
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Table 4
Pairwise comparison of groups using converted Cohen's d  effect size estimates for MMPI-2 
neurocorrection scales and the FBS.
Scale
TBI Simulators v. 
Controls
TBI v. 
Controls
TBI Simulators v. 
TBI
Gass 2.9 2.2 .86
Alfano 3.3* 1.5 .59
Artzy 2.0 .50 1.3
Gass & Russell 2.7 2.4 .40
Van Balen 2.8 2.3 .14
Fake Bad Scale 1.8 1.8 .51
Note: Pooled standard deviations based on unequal group size. Interpretation of effect sizes; 0-1: 
minimal effect; 1-2: small effect; 2-3: moderate effect; and 3-4: large effect.
*Meets clinically significant criteria (Zakzanis, 2001).
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Table 5
Logistic regression analysis for Alfano and the FBS predicting group 
membership.
Scale B SE
Wald
x2
Odds
ratio P
Alfano -1.6 .78 4.3 .21 .04
FBS -.52 .18 8.8 .56 .003
Note: B -  unstandardized regression coefficient. SE -  standard error.
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Table 6
Classification frequencies for Alfano and the FBS
Predicted
Scale Observed TBI simulator Control
Alfano Simulator 13 2
Control 1 16
FBS Simulator 11 4
Control 3 14
Note: Hit rate -  overall percentage correctly classified.
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Sensitivity, specificity, and hit rate for Alfano and the FBS.
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Scale & Sensitivity Specificity Hit Rate
cutoff
Alfano ( > 7) 86.7 94.1 90.6
FBS ( >18) 73.3 82.4 78.1
Note: Percentages for TBI simulators and student controls.
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Appendix A.
Participant Information and Consent Form
Title: The Effectiveness of Special Correction Scales o f the MMPI-2
Investigators
Paul Dukarm, Dept, of Psychology, The University of Montana, Missoula MT. 59812 
243-6347
Dr. Stuart Hall, Dept, of Psychology, The University of Montana, Missoula MT. 59812 
243-5667
Special Instructions to the potential subject
Thank you for considering participating in this study. This consent form may contain 
words that are unfamiliar to you. If the contents of this form are unclear, please as the 
person who gave you this form to explain it to you.
Purpose
The purpose of the current study is to examine how effective certain scales contained 
within a common measure of personality are at distinguishing between different types of 
people . By signing the form below, you are giving your voluntary consent to participate 
in this research study.
Procedures
As a participant in the current study, you will asked to provide “true” or “false” answers 
to a variety of questions about personality features. Your answers to these questions will 
be kept completely confidential. The personality form can take between 35 minutes to 
approximately 1-1/2 hours to complete. Completion of the form will take place in the 
Skaggs building, Room #246, located at the top of the stairs on the second floor, directly 
above the psychology department.
Risks / Discomforts
As a research participant, it is expected that the amount of discomfort you will experience 
as a result of this study will be minimal. It is possible that some of the questions on the 
inventory may cause you to feel uncomfortable due to their personal nature. If you
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
49
become uncomfortable, please feel free to discuss your concerns with the research 
examiner or contact the principal investigator or faculty supervisor at the numbers 
provided above. Additionally, you may feel fatigued due to the length of the inventory. If 
you feel as if you need to take a break from answering the questions, you will be allowed 
to take a brief break when it is needed.
Benefits
Participating in the current study may benefit you by assisting you in obtaining three (3) 
experimental research credits and providing you with exposure to scientific research in 
psychology. Your participation will also provide very beneficial information to 
researchers and professionals in the field of psychology.
Confidentiality
The information you provide will be held strictly confidential by the research examiners 
(*see limitations below). Your name will not be marked on the answer sheet or 
questionnaire. However, if you agree to participate in this study, you will need to sign 
this form, which will be kept in a separate and locked filing cabinet from all testing 
materials. We will have you note your age, gender, ethnicity, and years of education for 
demographic purposes, but this personal information will not be attached to this form that 
contains your name. All demographic information will be kept separate from your 
response form, and will be used for data analysis purposes only. You will be assigned an 
identification number that will be used to help the research team keep your data forms 
organized. The information you provide will be read only by the principal investigator 
(Paul Dukarm), the faculty supervisor (Dr. Stuart Hall), and individual research 
assistants. Your answers to the inventory will be kept a minimum of 5-years after the 
study has ended, however the demographic form will be destroyed at the conclusion of 
the current study. The data from this study will be used for research publication purposes 
only, as well as presentations for research at academic conferences.
* There are certain situations in which confidentiality may be breached. I f  you indicate 
that you have a desire to harm yourself or someone else during the course o f this 
experiment. I f  this situation occurs, you will be provided with information on where you 
may obtain mental health services. Because o f this, we also require that you provide your 
name and your telephone number below. I f  you do not have a telephone number, please 
indicate a phone number where you can be reached.
Print Name Telephone Number
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Although there is minimal risk associated with your participation in this study, The University of 
Montana requires that the following paragraph be included in all consent forms. “In the event 
that you are injured as a result of this research you should individually seek appropriate medical 
treatment. If the injury is caused by the negligence of the University or any of its employees, you 
may be entitled to reimbursement or compensation pursuant to the Comprehensive State 
Insurance Plan established by the Department o f Administration under the authority of M.C.A., 
Title 2, Chapter 9. If the event of a claim for such injury, further information may be obtained 
from the University’s Claims representative or University Legal Counsel. (Reviewed by 
University Legal Counsel, July 6, 1993.”
Voluntary Participation / Withdrawal
Your participation in this study is entirely voluntary, and you may withdraw without penalty or 
any negative consequences. If you choose to withdraw, all your records will be destroyed, ad the 
data you provided will not be used in this study. If you decide to withdraw from this study, you 
will still receive your experimental credits.
Questions
If you have questions about this study now or at any time during the examination, please feel free 
to ask the examiner. Additionally, you may contact the principal investigator (Paul Dukarm, 243- 
4521) if you have any further questions about the study. We will not be able to give you feedback 
regarding your responses, however, you will be provided with additional information at the 
conclusion of the study. This information will be presented in the form of a debriefing sheet. If 
you have any questions regarding your rights as a research participant, you may contact the 
Institutional review Board Chair at 243-6670.
Subjects Statement of Consent
I have read the above description of this study and have been informed of the benefits and risks 
involved. All of my questions have been answered to my satisfaction, and I have been provided 
with the principal investigators contact information and the faculty supervisor in the event that I 
have concerns or questions in the future. By signing below, I voluntarily agree to participate in 
this study and give my consent to the examiners to use the information I provide for the purposes 
o f this experiment.
Participant’s name - Printed
Participant’s signature
Examiner’s signature
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Code
Age________
Ethnicity: (Please Check One)
American Indian _________
Asian _ _ _ _ _ _
African American _ _ _ _ _
Hispanic _________
Caucasian
Years of Education
Please answer the questions below
Have you ever experienced a head injury or 
other neurological condition (e.g. concussion,
seizures, migraines)? Yes   N o  .
Please explain. LOC PTA______
Have you ever seen a psychiatrist, 
psychologist, or other mental health specialist
for psychological conditions? Y  N__
Please explain.
MMPI-2 Basic Scales T-Score
L ____
F  ___
K ____
1
2 ____
 3____
 4 ____
 5 ____
 6____
7
 8____
9 ____
0
Special Correction Scales - Raw 
Gass
Gass & Russell 
Van Balen et al. 
Alfano et al. 
Artzy
(Research staff only) Manipulation check: YES NO
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Appendix C.
MPM Participant Information Form
Code
Age Neurological Data
Ethnicity: (Please Check One) LOC
American Indian PTA
Asian
African American GCS
Hispanic
Caucasian PTS yes no
Years of Education
MMPI-2 Basic Scales T-Score Neurocorrection Scales - Raw
L Gass
F
K Gass & Russell
1 Van Balen
2
3 Alfano
4
5 Artzy
6
7 FBS
8
9
0
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Appendix D.
Head Injury Severity Classification Criteria
Traumatic Brain Injury
Measure Mild Moderate
Loss of Consciousness < 20 minutes 20 minutes - 36 hours
Post-traumatic Amnesia < 24 hours 1 -7  days
Glascow Coma Scale 13-15 9 - 1 2
Adapted from Williamson, Scott, and Adams (1996).
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Appendix E.
Instructions for Psychology Student Control Group.
Instructions will be read as follows:
" This inventory is comprised o f567 items that require you to answer either "true" or 
"false" to a variety o f questions regarding personal interests and behavior. Please read 
each item carefully and completely fill in the appropriate circle on your answer form. It 
is important for the purposes o f this study that you answer the items as honestly as 
possible, and i f  you come to a statement that you are unsure, answer the item whether it 
is "mostly true" or "mostly false". I f  you have any questions, please ask the examiner. 
When you are finished, please put your answer booklet in the envelope and turn it in to 
the examiner.
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Appendix F
Instructions for Student Head Injury Simulation Group
" This inventory is comprised o f567 items that require you to answer either 
"true" or "false" to a variety o f  questions regarding personal interests and behavior. 
Please read each item carefully and completely fill in the appropriate circle on your 
answer form.
While responding to the inventory, please pretend that you have experienced 
brain damage from a head-on motor vehicle accident. You hit your head against the 
windshield and were knocked out for about 15-minutes. Afterwards, you fe lt "dazed" so 
you were hospitalized overnight for observation. Because the driver o f  the car is at fault, 
you have decided to go to court and obtain compensation from the person responsible. 
During the next few months following the accident, the negative effects begin to 
disappear. Your lawsuit has not yet been settled, and your lawyer has told you that you 
may get more money i f  you look like you are still suffering from brain damage.
As you pretend to be this accident victim, try to respond to each item as a patient 
who is trying to appear brain damaged in order to get money from the lawsuit. Your 
performance on the inventory should convince the examiner as well as the people 
involved in deciding the outcome o f your lawsuit that you are still suffering from brain 
damage. I f  you are able to convince the examiner o f your condition, you will be given an 
extra (3) research credits fo r your participation.
Note: Instructions adapted from Thombaugh (1997), Rose et al. (1995), and Huskey & 
Hall (2003).
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Appendix G. 
Debriefing and Referral
Instructions to Examiner for Debriefing:
"Thank you for your participation in this experiment. You have just provided us with 
valuable information that will help us ascertain whether the inventory you just completed 
is helpful in allowing clinicians to detect persons who deliberately fake brain damage on 
tests ofpersonality. Although the study was a simulation o f neuropsychological 
impairment and litigation, the information you provided will nonetheless provide us with 
preliminary information regarding continued research in this are.
For control group:
As you were told prior to completing the MMPI-2, you will be given (3) research credits 
for your participation.
For experimental group:
You will receive six (3) credits fo r  your participation.
In the event that a participant has questions regarding the answers they provided or 
requests psychological services, they will be provided with the following 
information.
Contact and Referral for Psychological Intervention
Project Coordinator -  Paul Dukarm, M.A. 243-4521
Project Supervisor -  Stuart Flail, Ph.D. 243 -  5667
CAPS - Counseling and Psychological Services - Curry Health Center 
University of Montana, 243- 4711.
CPC -  Clinical Psychology Center -  1444 Mansfield Ave., University of Montana, 
243-2367.
WMMHC -  Western Montana Mental Health Center -  1315 Wyoming, Missoula MT., 
532-9700
Providence Center - St. Patrick’s Hospital, Missoula, MT.
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Appendix H.
Results o f Analysis o f Variance Comparing Groups on MMPI-2 Validity and Clinical 
Scales
Analysis of variance procedures for the Validity and Clinical scales were 
conducted to examine the current results in relation to previous research. Specifically, 
inspection of within and between groups differences on each scale would provide 
evidence of the consistency of scores related to previous studies examining TBI 
simulators and controls.
Appendix I presents means, standard deviations, and results of one-way ANOVA 
for MMPI-2 validity scales. Strength of association between each validity scale and 
group mean score is displayed as the eta-squared (r| ) effect size statistic. Tukey’s HSD 
test post hoc alpha levels were conducted in order to evaluate significant differences for 
each group pair. No significant differences between groups were observed on the VRIN, 
TRIN, L, and K validity scales.
One-way ANOVA revealed significant differences among groups on the F scale, 
[F (2, 54) = 38.9,p  < .05, r\2 = .60], Tukey’s HSD revealed that the TBI simulators 
differed significantly on the F scale from both controls and the community TBI patients, 
p  < .05. There were no significant differences observed between community TBI patients 
and student controls.
Significant differences were also observed among groups for the F(b) scale,[ F  (2, 
54) = 18.7, /? < .05, x\ = .42]. Tukey’s HSD revealed significant differences between the 
TBI simulators and both community TBI patients and controls,/? < .05. No significant 
differences were observed between the community TBI patients and controls.
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The F(p) scale demonstrated significant differences among the 3 groups, [F (2,
54) = 9.1 ,/? < .05, scale r\2 = .26]. Tukey’s HSD indicated that the TBI simulators 
produced mean scores that were significantly different from both the community TBI 
patients and controls, p  < .05. No significant differences were observed between the 
community TBI patients and controls.
Analysis o f variance comparing groups on MMPI-2 Clinical scales
The one-way ANOVA results revealed significant differences on scales 1,2, 3,6, 
7, 8, and 0 across groups and are displayed in Appendix J. Significant mean differences 
were observed among groups on scale 1, [F (2, 54) = 47.3, p  < .05]. Scale 1 generated a 
large overall effect size across groups, r\ = .65. Tukey’s HSD revealed that TBI 
simulators and community TBI patients differed significantly from controls,/? < .05, but 
not from each other.
A one-way ANOVA revealed significant mean differences on scale 2, [F (2, 54) = 
23.9,/? < .05, r \=  .48]. Tukey’s HSD revealed that TBI simulators and community TBI 
patients also differed significantly from controls,/? < .05. The TBI simulators did not 
significantly differ from community TBI patients.
Significant differences were also observed across groups on scale 3, F  (2, 54) = 
21.2,/? < .05, t |2 — .45. As with the two previous scales, Tukey’s HSD revealed that the 
TBI simulators and community TBI patients differed from controls,/? < .05, but not each 
other.
No differences were observed between groups on scale 4. The ANOVA revealed 
nonsignificant between group differences in mean scaled scores, [F (2, 54) = 3.9,/? = .05, 
p 2 = .13].
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Significant mean differences among groups were produced for scale 6, [F (2, 54)
= 11.6,p  < .05, r|2 = .41]. Tukey’s HSD revealed that TBI simulators differed 
significantly from control and community TBI patients,/? < .001. Community TBI 
patients significantly differed from controls,/? < .05.
Scale 7 also produced significant differences between groups, [F (2, 54) = 9.8,/? 
< .05, r| = .28]. Tukey’s HSD revealed TBI simulators and community TBI patients 
differed significantly than controls,/? < .05. TBI simulators did not significantly differ 
from the community TBI patient group.
One-way ANOYA revealed significant differences on scale 8 across groups, [F 
(2, 54) = 17.2,/? < .05, r|2= .40]. Tukey’s HSD revealed that the TBI simulators and 
community TBI patients significantly differed from controls,/? < .05. Community TBI 
patients also differed from controls and TBI simulators, p < .05.
No significant differences were observed between groups on scale 9. The 
ANOVA revealed nonsignificant between group differences in mean scaled scores, [F (2, 
54) = 3.8,/? = .05, r)2= .13].
Scale 0 produced significant mean differences among groups, [F (2, 54) = 7.1, p  < 
.05, r\2 = .22]. Tukey’s HSD test revealed that the TBI simulators and community TBI 
patients significantly differed from controls,/? < .05. No significant differences were 
found between TBI simulators and community TBI patients.
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Appendix I.
Analysis of variance comparing groups on MMPI-2 Validity scales.
TBI Simulators 
(n=15)
Student controls 
(n=17)
TBI
(n=22)
ANOVA
Scale Mean SD Mean SD Mean SD F(2, 54) rf
VRIN 60.1 15.3 53.8 10.6 55.5 11.1 1.1 .04
TRIN 61.8 13.9 54.1 5.0 57.6 7.2 .9 .10
F 97.1. 20.9 57.lb 12.1 59.5 b 10.2 38.9* .60
F(b) 91.1a 23.4 55.0b 21.1 56. lb 10.9 18.7* .42
m 83.1a 26.8 55.8b 21.3 53.7b 18.6 9.1* .26
L 53.1 12.8 45.5 12.6 55.0 10.2 3.7 .13
K 42.4 7.6 49.5 9.5 47.7 7.5 3.2 .11
Note: if-  eta-squared measure of effect size. Means in the same row that do not share subscripts 
differ significantly in the Tukey HSD comparison,* p < .05.
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Appendix J.
Analysis o f variance comparing groups on MMPI-2 K-corrected Clinical scales
Scale
TBI Simulators 
(n =15)
Student controls 
(n =17)
TBI
(n =22)
ANOVA
Mean SD Mean SD Mean SD F (2, 54) r?
IK 76.3a 13.0 40.2b 10.5 74.1. 13.0 47.3* .65
2 77.0a 16.4 48.0 8.8 70.1, 12.3 23.9* .48
3 77.6a 16.0 50.2b 9.1 79.4a 17.6 21.2* .45
4K 62.5 14.4 50.5 11.6 60.2 12.5 3.9 .13
6 80.3a 19.9 C/\ © cr 8.9 62.2C 12.5 17.6* .41
7K 62.9a 18.3 44.7a 14.5 66.1b 14.8 9.8* .28
8K 81.l a 21.3 46.4b 16.3 66.6C 13.7 17.2* .40
9K 64.9 11.8 56.4 13.9 52.5 14.2 3.8 .13
0 59.7a 15.3 44.5b 7.5 52.0a 12.7 7.1* .22
Note: if-  eta-squared measure of effect size. Means in the same row that do not share subscripts 
differ significantly in the Tukey HSD comparison, *p < .05.
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